Inotrem reports positive data from Phase IIa trial of nangibotide
Inotrem has reported positive results from a Phase IIa trial of nangibotide (LR12) for the treatment of septic shock patients.
septic shock Inotrem nangibotide
Inotrem has reported positive results from a Phase IIa trial of nangibotide (LR12) for the treatment of septic shock patients.